12 Best Nanotechnology Stocks to Buy According to Hedge Funds

2. Thermo Fisher Scientific Inc. (NYSE:TMO)

Number of Hedge Fund Holders: 98

Thermo Fisher Scientific Inc. (NYSE:TMO) delivers a wide array of products and services across life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products, serving markets worldwide. Earlier this year, the company unveiled advancements in nanotechnology and related tools, including new versions of its Orbitrap Ascend Tribrid Mass Spectrometer, designed for biopharma, structural biology, and multiomics research. Additionally, its Vanquish Neo UHPLC device enhances mass spectrometer efficiency by improving data collection and sample throughput.

On October 24, Thermo Fisher Scientific Inc. (NYSE:TMO) reported mixed Q3 earnings. The company posted an EPS of $5.28, slightly beating estimates, while revenue of $10.6 billion fell $30 million short of expectations. Despite this, Thermo Fisher raised its full-year EPS guidance to $21.35–$22.07, up from the prior range of $21.29–$22.07, while maintaining its revenue guidance between $42.4 billion and $43.3 billion.

On December 20, RBC Capital Markets adjusted its outlook on Thermo Fisher Scientific Inc. (NYSE:TMO), lowering the price target from $711 to $692 but maintaining an Outperform rating. RBC praised the company’s strong management and a 20+ year track record of successful consolidations and share price growth, highlighting its growth potential in the life sciences and diagnostics sector. While acknowledging potential revenue headwinds in 2025, RBC noted that buy-side expectations for organic growth are at 4%, slightly below the street average of 4.7%, which has been trending downward.